DrugPatentWatch Database Preview
Litigation Details for Antares Pharma Inc. v. Medac Pharma Inc. (Fed. Cir. 2014)
» See Plans and Pricing
Antares Pharma Inc. v. Medac Pharma Inc. (Fed. Cir. 2014)
| Docket | Start Trial | Date Filed | 2014-07-21 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 6,746,429; 7,449,012; 7,744,582; 7,776,015; 7,794,432; 8,048,035; 8,480,631; RE44,599; RE44,846 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Antares Pharma Inc. v. Medac Pharma Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , Start Trial , and Start Trial .
Details for Antares Pharma Inc. v. Medac Pharma Inc. (Fed. Cir. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-07-25 | 20 | IJ3, filed on Feb. 9, 2001, now PaL No. 6,746,429, which is a continuation of appli- …Furthermore, as auto-injectors operate like Pat. No. 6,746,429, which is a continuation of International …Antares patents, though this appeal focuses on one—RE 44,846 (“the ‘846 patent”). 1 The ‘846 patent “is …the two patents support two patentably distinct inventions. During prosecution of the ‘015 patent, the …015 patent. But that is not what happened. During the prosecution of the ‘846 patent, the Patent Office | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
